BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 37353291)

  • 1. Take a spin: Apheresis in the care of adult leukaemia patients.
    Ai J
    Best Pract Res Clin Haematol; 2023 Jun; 36(2):101467. PubMed ID: 37353291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Collection of hematopoietic progenitor cells from healthy donors].
    Bojanić I; Cepulić BG; Mazić S
    Acta Med Croatica; 2009 Jun; 63(3):237-44. PubMed ID: 19827352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Donor lymphocyte apheresis for adoptive immunotherapy compared with blood stem cell apheresis.
    Körbling M; Giralt S; Khouri I; Mirza N; Donato M; Anderlini P; Fischer H; Andreeff M; McMannis J; Champlin R
    J Clin Apher; 2001; 16(2):82-7. PubMed ID: 11746533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Harvesting and enrichment of hematopoietic progenitor cells mobilized into the peripheral blood of normal donors by granulocyte-macrophage colony-stimulating factor (GM-CSF) or G-CSF: potential role in allogeneic marrow transplantation.
    Lane TA; Law P; Maruyama M; Young D; Burgess J; Mullen M; Mealiffe M; Terstappen LW; Hardwick A; Moubayed M
    Blood; 1995 Jan; 85(1):275-82. PubMed ID: 7528570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant human granulocyte-colony-stimulating factor-mobilized and apheresis-collected endothelial progenitor cells: a novel blood cell component for therapeutic vasculogenesis.
    Körbling M; Reuben JM; Gao H; Lee BN; Harris DM; Cogdell D; Giralt SA; Khouri IF; Saliba RM; Champlin RE; Zhang W; Estrov Z
    Transfusion; 2006 Oct; 46(10):1795-802. PubMed ID: 17002637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Innovative two-step negative selection of granulocyte colony-stimulating factor-mobilized circulating progenitor cells: adequacy for autologous and allogeneic transplantation.
    Rambaldi A; Borleri G; Dotti G; Bellavita P; Amaru R; Biondi A; Barbui T
    Blood; 1998 Mar; 91(6):2189-96. PubMed ID: 9490708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allogeneic Hematopoietic Stem Cell Transplantation Mobilized With Pegylated Granulocyte Colony-Stimulating Factor Ameliorates Severe Acute Graft-Versus-Host Disease Through Enrichment of Monocytic Myeloid-Derived Suppressor Cells in the Graft: A Real World Experience.
    Li L; Yin J; Li Y; Wang C; Mao X; Wei J; Cao Y; Wang N; Lin L; Xu J; Zhang Y
    Front Immunol; 2021; 12():621935. PubMed ID: 33912154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allogeneic blood progenitor cell collection in normal donors after mobilization with filgrastim: the M.D. Anderson Cancer Center experience.
    Anderlini P; Donato M; Chan KW; Huh YO; Gee AP; Lauppe MJ; Champlin RE; Körbling M
    Transfusion; 1999 Jun; 39(6):555-60. PubMed ID: 10378833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. G-CSF-mobilized peripheral blood progenitor cells for allogeneic transplantation: safety, kinetics of mobilization, and composition of the graft.
    Dreger P; Haferlach T; Eckstein V; Jacobs S; Suttorp M; Löffler H; Müller-Ruchholtz W; Schmitz N
    Br J Haematol; 1994 Jul; 87(3):609-13. PubMed ID: 7527648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of granulocyte colony stimulating factor at content of donor lymphocytes collected for cellular immunotherapy.
    Arat M; Arslan O; Gürman G; Dalva K; Ozcan M; Uğur A; Ilhan O
    Transfus Apher Sci; 2004 Feb; 30(1):9-15. PubMed ID: 14746816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mobilization of hematopoietic progenitors from normal donors using the combination of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor results in fewer plasmacytoid dendritic cells in the graft and enhanced donor T cell engraftment with Th1 polarization: results from a randomized clinical trial.
    Lonial S; Akhtari M; Kaufman J; Torre C; Lechowicz MJ; Flowers C; Sinha R; Khoury HJ; Langston AA; Waller EK
    Biol Blood Marrow Transplant; 2013 Mar; 19(3):460-7. PubMed ID: 23201472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unstimulated leukapheresis in patients and donors: comparison of two apheresis systems.
    Schulz M; Bialleck H; Thorausch K; Bug G; Dünzinger U; Seifried E; Bönig H
    Transfusion; 2014 Jun; 54(6):1622-9. PubMed ID: 24299303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Manufacturing of highly functional and specific T cells for adoptive immunotherapy against virus from granulocyte colony-stimulating factor-mobilized donors.
    Beloki L; Ramírez N; Olavarría E; Samuel ER; Lowdell MW
    Cytotherapy; 2014 Oct; 16(10):1390-408. PubMed ID: 24954783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The healthy donor profile of immunoregulatory soluble mediators is altered by stem cell mobilization and apheresis.
    Melve GK; Ersvaer E; Paulsen Rye K; Bushra Ahmed A; Kristoffersen EK; Hervig T; Reikvam H; Hatfield KJ; Bruserud Ø
    Cytotherapy; 2018 May; 20(5):740-754. PubMed ID: 29576502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary transplantation of allogeneic peripheral blood progenitor cells mobilized by filgrastim (granulocyte colony-stimulating factor).
    Schmitz N; Dreger P; Suttorp M; Rohwedder EB; Haferlach T; Löffler H; Hunter A; Russell NH
    Blood; 1995 Mar; 85(6):1666-72. PubMed ID: 7534141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pediatric therapeutic apheresis: rationale and indications for plasmapheresis, cytapheresis, extracorporeal photopheresis, and LDL apheresis.
    Kim YA; Sloan SR
    Pediatr Clin North Am; 2013 Dec; 60(6):1569-80. PubMed ID: 24237988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modification of NK cell subset repartition and functions in granulocyte colony-stimulating factor-mobilized leukapheresis after expansion with IL-15.
    Xiong Y; Mouginot M; Reppel L; Qian C; Stoltz JF; Bensoussan D; Decot V
    Immunol Res; 2017 Dec; 65(6):1130-1138. PubMed ID: 29019081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences in Cellular Composition of Peripheral Blood Stem Cell Grafts from Healthy Stem Cell Donors Mobilized with Either Granulocyte Colony-Stimulating Factor (G-CSF) Alone or G-CSF and Plerixafor.
    Teipel R; Oelschlägel U; Wetzko K; Schmiedgen M; Kramer M; Rücker-Braun E; Hölig K; von Bonin M; Heidrich K; Fuchs A; Ordemann R; Kroschinsky F; Bornhäuser M; Hütter G; Schmidt H; Ehninger G; Schetelig J; Heidenreich F
    Biol Blood Marrow Transplant; 2018 Nov; 24(11):2171-2177. PubMed ID: 29935214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mobilization kinetics of CD34+ hematopoietic stem cells stimulated by G-CSF and cyclophosphamide in patients with multiple sclerosis who receive an autotransplant.
    Jaime-Pérez JC; Gómez-Galaviz AC; Turrubiates-Hernández GA; Picón-Galindo E; Salazar-Riojas R; Méndez-Ramírez N; Gómez-Almaguer D
    Cytotherapy; 2020 Mar; 22(3):144-148. PubMed ID: 32057615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Technical and safety aspects of blood and marrow transplantation using G-CSF mobilized family donors.
    Kadar JG; Arseniev L; Schnitger K; Südmeier I; Zaki M; Battmer K; Jacobs R; Diedrich H; Poliwoda H; Stangel W; Link H
    Transfus Sci; 1996 Dec; 17(4):611-8. PubMed ID: 10168561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.